Fifth Dimension    Catalog    Contact Us
graphic to create line
Cancer Supportive and Survivorship Care Programs Improving Quality of Life Logo

Estrogen and Progestin Bioactivity of Foods, Herbs, and Spices (44247) References
David T. Zava, PhD, Charles M. Dollbaum, MD, PhD, and Marilyn Blen
Reprinted by permission Society for Experimental Biology and Medicine

Abstract
Introduction
Methods

Results
Progestin-Mediated Down Regulation of ER as an Index of Progestin-Agonist/Antagonist Activity of Herbal Extracts
Discussion

Permission
Acknowledge
Table I - Alphabetical Listing of Herbs Studied
Table 2 - Herbs and Spices Containing ER Binding Components

Table 3 - Herbs and Spices Containing PR Binding Components
Figure I - Protein/Well ER (+)

Figure 2 - Protein/Well ER (-)
Figure 3 - nmoles PNP formed/min / µg protein

Figure 4 - fmoles Estrogen Receptor/ µg DNA
Figure 5 - Log Progesterone Concentration (pg/ml)

Figure 6 - PR Binding (pg/ml Pg Equivalents)
Figure 7 - Hours Post SoyMilk Ingestion

1. Duke JA. Handbook of Medicinal Herbs.
Boca Raton, FL: CRC Press, 1985.
2. Erichsen-Brown C. Medicinal and Other Uses of North American Plants: A Historical Survey with Special Reference to the Eastern Indian Tribes. New York:
Dover Publications, Inc., 1979.
3. Beckham N. Phyto-oestrogens and compounds that affect oestrogen metabolism.
Aust J Med Herbalism 7(1), 1995.
4. Farnsworth NR. Bingel AS, Cordell GA, Crane FA. Fong HHS. Potential value of plants as sources of new antifertility agents 11.
J Pharmaceutical Sci 64:717- 754, 1975.
5. Avis NE, Kaufert PA, Lock MA, McKinlay SM, Vass K. The evolution of menopausal symptoms.
Clin Endo Metab 7:17-32, 1993.
6. Davis DL. Bradlow HL. Can environmental estrogens cause breast cancer?
Scientific American Oct:169-172, 1995.
7. Safe SH. Do environmental estrogens play a role in development of breast cancer in women and male reproductive problems?
Human and Ecol Risk Assessment 1:17-23. 1995.
8. Safe SH. Environmental and dietary estrogens and human health: Is there a problem?
Environ Health Perspect 103:346-351. 1995.
9. Ojasoo 1. Raynaud JP. Dore JC. Affiliations among steroid receptors as revealed by multivariate analysis of steroid binding data.
J Steroid Biochem Mol Biol 48:31-46, 1994.
10. Gupta C, Bullock LP, Bardin CW. Further studies on the androgenic, anti-androgenic, and synandrogenic actions of progestins.
Endocrinology 120:736-744, 1978.
11. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
Nutr Cancer 27:31-40, 1997.
12. McLachlan JA. Functional toxicology: A new approach to detect biologically active xenobiotics.
Environ Health Perspect 101:386-387, 1993.
13. Solo AM, Lin T, Justicia H, Silvia RM, Sonnenschein C. An culture' bioassay to assess the estrogenicity of xenobiotics (EScreen). In: Colbum T, Clement C, Eds. Chemically-Induced Alterations in Sexual and Functional Development:The WildlifeIHuman Connection. Princeton. NJ:
Princeton Scientific Publishing Co.. pp295-309. 1992.
14. DiLorenzo DD. Albertini A, Zava DT. Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D.
Cancer Res 51:4470-4475, 1991.
15. Mauvais-Jarvis P. Kutten F. Gompet A. Estradiollprogesterone interaction in normal and pathologic breast cells.
Ann N Y Acad Sci 464:152-167. 1986.
16. Eckert RL. Katzenellenbogen BS. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF7 human breast cancer cells.
Cancer Res 42:139-144, 1982.
17. Ellison PT. Measurements of salivary progesterone.
Ann N Y Acad Sci 694:161-176, 1993.
18. Adlercreutz H. Goldin BR, Gorbach SL. Hockerstedt KA, Watanabe S. l-Iamalainen EK, Markkanen MH, Makela TH, Wahala KT. Soybean phytoestrogen intake and cancer risk.
J Nutr 125:757S-770S, 1995.
19. Messina MJ, Persky V. Setchell KDR, Barnes S. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer 21:113131, 1994.
20. Franke AA, Custer U, Cerna CM, Narala KK. Quantitation of phytoestrogens in legumes by HPLC.
J Agric Food Chem 42:1905-1913, 1994.
21. Wang C, Mlkela I, Hase T, Adlercreutz H, Kurzer MS. Lignans and isoflavonoids inhibit aromatase enzyme in human preadipocytes.
Steroid Biochem Mol Biol, 1994.
22. Makela 5, Poutanen M, Lehtimaki J, Kostian ML. Santti R, Vihko R. Estrogen-specific 1713- hydroxysteroid oxidoreductase Type I as a possible target for the action of phytoestrogens.
Proc Soc Exp Biol Med 208:51-59, 1995.
23. Stoll W. Phytopharmacon influences atrophic vaginal epithelium:
Double-blind study of Cimicifuga versus estrogenic substances.
Therapeuticum 1:23-31. 1987.
24. Chury J. Uber den phytoostrogengehalt einiger pflanzen.
Experentia 16:194-200, 1960.
25. Rosenblum ER, Campbell IM, Van Thiel DH. Gavaler JS. Isolation and identification of phytoestrogens from beer. Alcoholism.
Clin Exp Res 16:843-845, 1992.
26. Fenselau C, Talalay P. Is oestrogenic activity present in hops? Fd Cosmet Toxicol 11:597- 603, 1973.
27. Khwaja TA, Dias CB, Pentecost S. Recent studies on the anticancer activities of mistletoe (Viscum albumin) and its alkaloids.
Oncology 43S:2-7, 1986.
28. Prior JC, Vigna YM, Barr SI, Rexworthy C. Lentle BC. Cyclic medroxyprogesterone treatment increases bone density: A controlled trial in active women with menstrual cycle disturbances.
Am J Med 96:521-530,1994.
29. Follow K, Lubbert H, Boquoi E. Follow B. Progesterone metabolism in normal human endometrium during the menstrual cycle and in endometrial carcinoma.
J Clin Endocrinol Metab 41:729-737. 1975.
30. Gupta C. Bullock LP. Bardin CW. Further studies on the androgenic. anti- androgenic. and synandrogenic actions of progestins.
Endocrinology 102:736-744. 1978.
31. Dentali S. Hormones and yams: What's the connection?
The American Herb Assoc 10:4-5. 1994.
32. Gaby A. Multilevel yam scam.
Townsend Letter for Doctors and Patients Jan:96-97. 1996.
33.Kumagai A, Nishino K. Shimomora A, Kin I. Yamamura Y. Effect of glycyrrhizin on estrogen action.
Endocrinol Japan 14:34-38, 1967.
34.Kraus S. The anti-estrogenic action of beta- glycyrrhetinic acid.
Exp Med Surg 27:411- 420, 1969.

Permission
Back to the Table Of Contents


Permission granted by the publisher and authors:
Copyright © 1998 The Proceedings of the Society for Experimental Biology and Medicine 1998 Mar;217(3):369-78
Society for Experimental Biology and Medicine
http://www.sebm.org/
Aeron LifeCycles Clinical Laboratory
http://www.aeron.com
ZRT Laboratory
http://www.zrtlab.com/

Requests for reprints should be addressed to
Aeron LifeCycles Clinical Laboratory
1933 Davis St.. Suite 310, San Leandro, CA. 94577.




You are welcome to share this © article with friends, but do not forget to include the author name and web address. Permission needed to use articles on commercial and non commercial websites. Thank you.